New research findings presented at the 2019 ACR/ARP Annual Meeting found a strong association between changes in atmospheric and environmental variables 10 days before a clinic visit and organ-specific lupus flares in patients ...
Nov 10, 2019
0
52
A phase II clinical trial found that rilonacept, an inhibitor of the protein interleukin-1 (IL-1), significantly reduced acute gout flares that occur when initiating uric acid-lowering therapy. Results of the trial—the ...
Jan 5, 2012
0
0
New research shows that African Americans with systemic lupus erythematosus (SLE) had a higher antibody response to influenza vaccination than European American patients. Treatment with prednisone, a history of hemolytic ...
May 19, 2011
0
0
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, has found that rheumatoid arthritis (RA) patients in sustained remission who stopped TNF inhibitors (TNFi) had significantly ...
Nov 10, 2023
0
1
The risk for hospitalization doubles for kids with asthma who are exposed to secondhand smoke, according to a study led by Mayo Clinic Children's Research Center.
Sep 24, 2015
0
16
Refuting a belief long held by many physicians, a Mayo Clinic study found that rheumatoid arthritis patients also can get gout. The research is among several studies Mayo Clinic is presenting at the American College of Rheumatology ...
Nov 10, 2012
0
0
Use of inhaled anticholinergics (IACs) has been associated with an increased risk of potentially dangerous heart arrhythmias among young asthma patients, according to a study conducted by researchers at the University of ...
May 22, 2012
0
0
In a study of 1,377 patients with rheumatic and musculoskeletal diseases—such as inflammatory arthritis and lupus—flares of their conditions were uncommon following two-dose COVID-19 mRNA vaccination. In a study of 1,377 ...
Aug 4, 2021
0
2
(HealthDay)—A large new study of Danish women has tied a mother's asthma during pregnancy to a higher risk for developing a wide range of childhood diseases among her offspring.
Aug 5, 2013
0
0
The U.S. Food and Drug Administration has approved SPEVIGO (spesolimab-sbzo) as the first treatment option for generalized pustular psoriasis (GPP) flares in adults.
Sep 7, 2022
0
1
